Prognostic implications of small left atria on hospitalized patients.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 Sep 2019
Historique:
received: 18 01 2018
accepted: 21 12 2018
pubmed: 29 1 2019
medline: 1 12 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

To demonstrate the association between small left atria (LA) and outcome in a relatively large heterogeneous population of hospitalized patients. In a single-centre retrospective study, all inpatients that underwent an echocardiographic assessment between 2011 and 2016 and had an available left atrial volume index (LAVI) measurement were included. The cohort consisted of 17 343 inpatients who had an available LAVI measurement, 288 with small LA (LAVI <16 mL/m2), 7531 patients had LAVI within normal limits (16-34 mL/m2) divided into low normal (16-24.9 mL/m2; n = 2636) and high normal (25-34 mL/m2; n = 4895), 4720 patients had large LAVI (34.1-45 mL/m2) and 4804 had very large LAVI (>45 mL/m2). Median follow-up time was 2.4 years. After adjustments for age, gender, and baseline characteristics with a P-value <0.2 in univariable analyses (body mass index, haemoglobin, ischaemic heart disease, valvulopathy, atrial fibrillation, diabetes mellitus, hypertension, hyperlipidaemia, smoking, renal dysfunction, lung disease, and malignancy) small LA was associated with a higher risk for in-hospital mortality (odds ratio 2.9, 95% confidence interval (CI) 1.4-5.7; P = 0.002] and all-cause mortality [hazard ratio (HR) 2.1, 95% CI 1.6-2.8; P < 0.001] compared with high normal LA. For every mL/m2 decrease below high normal LA size the risk for in-hospital and long-term all-cause mortality increased by 10% (HR 1.1, 95% CI 1.02-1.18; P = 0.005) and 8% (HR 1.08, 95% CI 1.05-1.12; P < 0.001), respectively. Small LA are independently associated poorer short- and long-term mortality. LA volume should be referred to as J-shaped in terms of mortality. 0170-17-TLV.

Identifiants

pubmed: 30689832
pii: 5299613
doi: 10.1093/ehjci/jey230
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1051-1058

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Zach Rozenbaum (Z)

Department of Cardiology, Tel Aviv Medical Center, 6 Weizman St, Tel Aviv 64239, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.

Yan Topilsky (Y)

Department of Cardiology, Tel Aviv Medical Center, 6 Weizman St, Tel Aviv 64239, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.

Galit Aviram (G)

Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
Department of Radiology, Tel Aviv Medical Center, 6 Weizman St, Tel Aviv 64239, Israel.

Michal Entin-Meer (M)

Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
Cardiovascular Research Laboratory, Tel Aviv Medical Center, 6 Weizman St, Tel Aviv 64239, Israel.

Yoav Granot (Y)

Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
Department of Internal Medicine, Tel Aviv Medical Center, 6 Weizman St, Tel Aviv 64239, Israel.

David Pereg (D)

Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
Department of Cardiology, Meir Medical Center, 59 Tchernichovsky St, Kfar Saba, Israel.

Shlomo Berliner (S)

Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
Department of Internal Medicine, Tel Aviv Medical Center, 6 Weizman St, Tel Aviv 64239, Israel.

Arie Steinvil (A)

Department of Cardiology, Tel Aviv Medical Center, 6 Weizman St, Tel Aviv 64239, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.

Simon Biner (S)

Department of Cardiology, Tel Aviv Medical Center, 6 Weizman St, Tel Aviv 64239, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH